At a glance
ClinicalIndex Comparison RecordN/ACompleted· 34,100 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Transatlantic Active Surveillance on Cardiovascular Safety of NuvaRing (TASC)
Center for Epidemiology and Health Research, Germany·observational·Posted Sep 5, 2007·Updated Apr 9, 2014
In Brief
An observational study for Contraception. Completed, enrolled 34,100 participants across 1 site.
Detailed Summary
The objective of this study is to characterize and compare the risks of short- and long-term use of NuvaRing® with marketed combined oral contraceptives.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsContraception
CountriesGermany
CollaboratorsOrganon
Timeline
N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartSep 2007
First PostedSep 2007
Primary CompletionMar 2012
Study CompletionJun 2012
TodayJul 2026
First PostedSep 5, 2007
Enrollment StartSep 1, 2007
Primary CompletionMar 1, 2012
Study CompletionJun 1, 2012
TodayJul 2, 2026
Enrollment to primary: 4.5 yearsPosted 18.8 years ago